Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficient Ligand Discovery Using Sulfur(VI) Fluoride Reactive Fragments. | ACS Chem Biol | 2023 | 37084287 | PubTator, text mining | PubMed |
| Lenalidomide Stabilizes Protein-Protein Complexes by Turning Labile Intermolecular H-Bonds into Robust Interactions. | J Med Chem | 2023 | 37083375 | PubTator, text mining | PubMed |
| UPS: Opportunities and challenges for gastric cancer treatment. | Front Oncol | 2023 | 37077823 | PubTator, text mining | PubMed |
| Photoswitchable Molecular Glues Enable Optical Control of Transcription Factor Degradation. | bioRxiv | 2023 | 37066279 | PubTator, text mining | PubMed |
| Multifunctional activity-based chemical probes for sirtuins. | RSC Adv | 2023 | 37063743 | PubTator, text mining | PubMed |
| Advances in the multi-omics landscape of follicular lymphoma. | Int J Biol Sci | 2023 | 37063433 | PubTator, text mining | PubMed |
| Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH). | Clin Hematol Int | 2023 | 37060392 | PubTator, text mining | PubMed |
| Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. | Blood Adv | 2023 | 37058477 | PubTator, text mining | PubMed |
| Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review. | Transl Lung Cancer Res | 2023 | 37057106 | PubTator, text mining | PubMed |
| The NF-ĸB p50 subunit generated by KPC1-mediated ubiquitination and limited proteasomal processing, suppresses tumor growth. | Cancer Cell Int | 2023 | 37055826 | PubTator, text mining | PubMed |
| Potential Therapeutic Value of the STING Inhibitors. | Molecules | 2023 | 37049889 | PubTator, text mining | PubMed |
| BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications. | Molecules | 2023 | 37049806 | PubTator, text mining | PubMed |
| Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. | Molecules | 2023 | 37049739 | PubTator, text mining | PubMed |
| Ca2+-Activated K+ Channels in Progenitor Cells of Musculoskeletal Tissues: A Narrative Review. | Int J Mol Sci | 2023 | 37047767 | PubTator, text mining | PubMed |
| Regulation of Ubiquitin Family Signaling in Disease. | Int J Mol Sci | 2023 | 37047708 | PubTator, text mining | PubMed |
| Emerging Personalized Opportunities for Enhancing Translational Readthrough in Rare Genetic Diseases and Beyond. | Int J Mol Sci | 2023 | 37047074 | PubTator, text mining | PubMed |
| Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice. | Cancers (Basel) | 2023 | 37046821 | PubTator, text mining | PubMed |
| EBV and Lymphomagenesis. | Cancers (Basel) | 2023 | 37046794 | PubTator, text mining | PubMed |
| Anti-Angiogenic Activity of Drugs in Multiple Myeloma. | Cancers (Basel) | 2023 | 37046651 | PubTator, text mining | PubMed |
| 30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma. | Cancers (Basel) | 2023 | 37046589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=38